Back to search results

Epidemiology and Biomarker Study in Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE3

Conditions

Alzheimer Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Care Access - Houston, Houston, Texas, United States

    Study coordinator · 877-791-0656
    Contact: Principal Investigator (Ali Bajwa)

  • The University of Tokyo Hospital, Bunkyō City, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Yoshiki Niimi)

  • Souseikai Sumida Hospital, Tokyo, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Takuma Yonemura)

  • Higashi Shinjuku Clinic, Tokyo, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hiroaki Kondo)
Study leads

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

View source on ClinicalTrials.gov(opens in a new tab)